José Garnacho‐Montero

Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis*

José Garnacho‐Montero, J.L. García Garmendia, A Barrero-Almodóvar et al. · Critical Care Medicine · 2003 · 717 citations

A bedside scoring system (“Candida score”) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization*

Cristóbal León, Sergio Ruiz‐Santana, Pedro Saavedra et al. · Critical Care Medicine · 2006 · 635 citations

Treatment of Multidrug‐Resistant<i>Acinetobacter baumannii</i>Ventilator‐Associated Pneumonia (VAP) with Intravenous Colistin: A Comparison with Imipenem‐Susceptible VAP

José Garnacho‐Montero, Carlos Ortíz-Leyba, F. J. Jiménez-Jiménez et al. · Clinical Infectious Diseases · 2003 · 468 citations

Antimicrobial Susceptibility, Health Sciences, Antibiotics +11

Critical illness polyneuropathy: risk factors and clinical consequences. A cohort study in septic patients

José Garnacho‐Montero, Juan Madrazo-Osuna, J.L. García Garmendia et al. · Intensive Care Medicine · 2001 · 399 citations · Full text

Critical Care Medicine, Clinical Consequences, Acute Care +10

De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock

José Garnacho‐Montero, Ana Escoresca‐Ortega, Y. Corcia-Palomo et al. · Intensive Care Medicine · 2013 · 386 citations · Full text

Critical Care Medicine, Severe Sepsis, Acute Care +8